All articles by GlobalData

GlobalData

@globaldataplc

GlobalData at ISPOR Europe in Vienna – come see our posters!

GlobalData is pleased to be attending the ISPOR Europe Conference in Vienna, Austria, from 6–9 November 2022.

Global rheumatologists’ biosimilar prescription rates shift from 2018 to 2020

The rate of biosimilar adoption for the treatment of autoimmune diseases varies greatly by geographical market.

Over 50% of all chronic hepatitis B cases go undiagnosed in the 9MM

Chronic hepatitis B (CHB) is a viral liver disease that develops when the immune system cannot fight the hepatitis B virus and it remains in the body for six months or longer.

There is not enough evidence to blame India’s second wave of COVID-19 on mutations

Despite the alarming spike in new cases with India’s second wave, there is simply not enough evidence to place blame on variants.

Bunge Loders Croklaan launches premium lipid ingredient for infant milk formulas

Bunge Loders Croklaan, an oils and fat solutions provider for the global food industry, unveiled a new lipid ingredient called Betapol Select that is claimed to make infant milk formula more suitable for Chinese babies.

Twitter round-up: Prof Peter Hotez’s tweet on New Zealand’s measles outbreak top tweet in Q4 2019

Pharmaceutical Technology lists ten of the top tweets on infectious diseases in Q4 2019, based on data from GlobalData’s Influencer Platform.
The top tweets were chosen from influencers as tracked by GlobalData’s Influencer Platform, which is based on a scientific process that works on pre-defined parameters. Influencers are selected after a deep analysis of the influencer’s relevance, network strength, engagement, and leading discussions on new and emerging trends.